[1] Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)[J].J Am Coll Cardiol,2008,52(8):686-717. [2] 刘然,陆菊明,刘剑峰,等.2型糖尿病患者阻塞性睡眠呼吸暂停综合症患病情况及相关因素分析[J].中华老年心血管病杂志,2013,15(1):29-31. [3] 朱红霞,梁新华,王敏哲. 2型糖尿病合并阻塞性睡眠呼吸暂停综合症相关危险因素分析[J].实用预防医学,2015,22(12):1457-1459. [4] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2007 年版)[J].中华医学杂志,2008,88(18):1227-1245. [5] 中华医学会呼吸病学分会睡眠呼吸疾病学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J].中华结核和呼吸杂志,2012,35(1):9-12. [6] Foster GD, Sanders MH, Millman R, et al. Obstructive sleep apnea among obese patients with type 2 diabetes[J]. Diabetes Care,2009,32:1017-1019. [7] Lam DC, Lui MM, Lam JC, et al. Prevalence and recognition of obstructive sleep apnea in Chinese patients with type 2 diabetes mellitus[J]. Chest,2010,138: 1101-1107. [8] 苏有玲. 解毒降糖合剂对2型糖尿病患者炎性因子影响的观察[J].中医临床研究,2015,7(1):7-9. [9] 李胜利. 阻塞性睡眠呼吸暂停低通气综合征患者血清C反应蛋白和白细胞介素水平的变化及意义[J].当代医学,2013,19(1):7-9. [10] 王东,刘颖,宋艳红,等.阻塞性睡眠呼吸暂停综合征患者嗜睡程度与细胞因子水平的关系[J].国际呼吸杂志,2007,27(18):1375-1376. [11] 黄旭东,郑晓鹏,刘少漫,等. 炎性因子TNF-α IL-6脂联素与2型糖尿病相关性的研究[J].河北医学,2013,19(3):327-329. [12] 袁冰. nCPAP治疗合并中重度OSAS的脑血管病患者血清炎性因子水平的影响[D]. 石家庄:河北医科大学,2013. [13] 朱会分,张东会,李江力,等. 阻塞性睡眠呼吸暂停低通气综合征患者血清中炎性因子的变化[J].中国民族民间医药杂志,2010,19(1):62-63.
2016, Vol. 23 
